Valuation Inter Pharma

Stocks

End-of-day quote Thailand S.E. Other stock markets 2026-07-14			5-day change	1st Jan Change
4.960 ^THB	+2.48%		+9.73%	+7.83%

05-11	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-02	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	2,699	5,811	5,513	3,353	1,949	2,785
Change	-	115.34%	-5.13%	-39.19%	-41.86%	42.86%
Enterprise Value (EV) ¹	2,666	5,993	5,275	3,339	2,158	2,904
Change	-	124.78%	-11.98%	-36.69%	-35.37%	34.56%
P/E	50.2x	54.2x	40.6x	66x	52.3x	22.8x
PBR	5.73x	7.63x	2.86x	1.75x	1.01x	1.35x
PEG	-	0.6x	33.47x	-1.1x	-2x	0x
Capitalization / Revenue	6.04x	6.31x	3.59x	1.86x	1.02x	1.26x
EV / Revenue	5.97x	6.51x	3.44x	1.86x	1.13x	1.31x
EV / EBITDA	32.4x	35x	25.3x	19.9x	15.6x	10.7x
EV / EBIT	34x	41.1x	30.7x	30.5x	28.6x	15.1x
EV / FCF	112x	-18.9x	134x	-63.8x	-22.3x	31.7x
FCF Yield	0.89%	-5.3%	0.75%	-1.57%	-4.48%	3.16%
Dividend per Share ²	0.0103	-	0.1108	0.0214	-	0.073
Rate of return	0.18%	-	1.22%	0.39%	-	1.59%
EPS ²	0.1147	0.2214	0.2241	0.0839	0.0616	0.2022
Distribution rate	8.98%	-	49.4%	25.5%	-	36.1%
Net sales ¹	446.9	921	1,534	1,799	1,912	2,214
EBITDA ¹	82.3	171.4	208.7	167.7	138.3	272.5
EBIT ¹	78.5	145.8	171.7	109.4	75.53	192
Net income ¹	53.78	105.2	119.2	50.79	37.28	122.4
Net Debt ¹	-32.53	181.5	-238.3	-13.3	208.9	119.3
Reference price ²	5.758	12.000	9.108	5.538	3.220	4.600
Nbr of stocks (in thousands)	468,650	484,267	605,346	605,346	605,344	605,344
Announcement Date	2/25/21	2/25/22	2/28/23	3/1/24	2/25/25	3/2/26

¹THB in Million²THB

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
INTER PHARMA	-	-	-	-	87.62M
ELI LILLY AND COMPANY	34.43x	12.54x	25.95x	0.57%	1,054B
JOHNSON & JOHNSON	27.51x	6.31x	17.15x	2.07%	621B
ABBVIE INC.	30.73x	7.36x	15.07x	2.77%	438B
ROCHE HOLDING AG	17.67x	4.38x	10.82x	3.03%	325B
NOVARTIS AG	21.42x	5.5x	13.31x	2.87%	281B
ASTRAZENECA PLC	21.07x	4.44x	12.4x	1.98%	262B
NOVO NORDISK A/S	14.26x	5.33x	10.96x	3.5%	219B
AMGEN INC.	23.64x	6.27x	11.07x	2.8%	195B
GILEAD SCIENCES, INC.	-47.34x	5.67x	31.3x	2.47%	163B
Average	15.93x	6.42x	16.45x	2.45%	355.63B
Weighted average by Cap.	23.64x	7.82x	18.21x	2%